We are live on
!
Find out more
OC
Oarsman Capital Portfolio holdings
AUM
$806M
1-Year Est. Return
19.96%
This Fund
S&P 500
This Quarter
Est. Return
+6.16%
1 Year Est. Return
+19.96%
3 Year Est. Return
+61.37%
5 Year Est. Return
+74.92%
10 Year Est. Return
+242.94%
AUM
$543M
AUM Growth
+$86.5M
(+19%)
Cap. Flow
+$60.6M
Cap. Flow
% of AUM
11.16%
Top 10 Holdings %
Top 10 Hldgs %
38.61%
Holding
907
New
674
Increased
113
Reduced
96
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$12.8M |
| 2 |
Schwab International Equity ETF
SCHF
|
+$4.5M |
| 3 |
Goldman Sachs Physical Gold ETF Shares
AAAU
|
+$3.61M |
| 4 |
iShares Core Universal USD Bond ETF
IUSB
|
+$3.32M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$1.98M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$5.47M |
| 2 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$2M |
| 3 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$1.42M |
| 4 |
Ulta Beauty
ULTA
|
+$1.19M |
| 5 |
iShares Gold Trust Micro
IAUM
|
+$917K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.34% |
| 2 | Healthcare | 5.1% |
| 3 | Financials | 5.05% |
| 4 | Communication Services | 4.67% |
| 5 | Industrials | 4.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Huntington Ingalls Industries
HII
$12.7B
| $19.8K | ﹤0.01% |
+75
| New | +$19.8K |
|
602
Exponent
EXPO
$3.21B
| $19.8K | ﹤0.01% |
+172
| New | +$18K |
|
603
Visteon
VC
$2.75B
| $19.7K | ﹤0.01% |
+207
| New | +$21K |
|
604
ProShares Short S&P500
SH
$902M
| $19.5K | ﹤0.01% |
+450
| New | +$20.4K |
|
605
iShares S&P Mid-Cap 400 Growth ETF
IJK
$11B
| $19.3K | ﹤0.01% |
+210
| New | +$18.8K |
|
606
State Street Health Care Select Sector SPDR ETF
XLV
$42.4B
| $19.1K | ﹤0.01% |
+124
| New | +$18.8K |
|
607
VanEck Pharmaceutical ETF
PPH
$934M
| $19K | ﹤0.01% |
+200
| New | +$19K |
|
608
iShares 10-20 Year Treasury Bond ETF
TLH
$10.9B
| $18.3K | ﹤0.01% |
+167
| New | +$17.9K |
|
609
WisdomTree Japan SmallCap Dividend Fund
DFJ
$398M
| $18.1K | ﹤0.01% |
+225
| New | +$17.3K |
|
610
Check Point Software Technologies
CHKP
$12.8B
| $18.1K | ﹤0.01% |
+94
| New | +$17.2K |
|
611
Avantor
AVTR
$8.91B
| $18.1K | ﹤0.01% |
+700
| New | +$17.2K |
|
612
JPMorgan Realty Income ETF
JPRE
$484M
| $18.1K | ﹤0.01% |
+355
| New | +$17.1K |
|
613
Aecom
ACM
$9.63B
| $18.1K | ﹤0.01% |
+175
| New | +$16.4K |
|
614
Novanta
NOVT
$5.82B
| $17.9K | ﹤0.01% |
+100
| New | +$17.4K |
|
615
State Street
STT
$50.8B
| $17.7K | ﹤0.01% |
+200
| New | +$16.5K |
|
616
Nuveen Short-Term REIT ETF
NURE
$35.4M
| $17.6K | ﹤0.01% |
+520
| New | +$17K |
|
617
Wendy's
WEN
$1.41B
| $17.5K | ﹤0.01% |
+1,000
| New | +$17K |
|
618
The Mosaic Company
MOS
$7.46B
| $17.4K | ﹤0.01% |
+650
| New | +$17.9K |
|
619
Aon
AON
$76.5B
| $17.3K | ﹤0.01% |
+50
| New | +$16.4K |
|
620
Kraft Heinz
KHC
$29.6B
| $17.2K | ﹤0.01% |
+490
| New | +$16.9K |
|
621
CRISPR Therapeutics
CRSP
$4.99B
| $17.2K | ﹤0.01% |
+366
| New | +$18.6K |
|
622
M/I Homes
MHO
$3.71B
| $17.1K | ﹤0.01% |
+100
| New | +$15.2K |
|
623
Cognex
CGNX
$11.2B
| $17.1K | ﹤0.01% |
+422
| New | +$18K |
|
624
Neogen
NEOG
$2.46B
| $17K | ﹤0.01% |
+1,011
| New | +$16.6K |
|
625
Vital Farms
VITL
$536M
| $16.8K | ﹤0.01% |
+480
| New | +$17K |
|
Similar funds
RIM
BCM
GCM
CL
AF
UM
ACM
AAM
Oarsman Capital's Q3 2024 Portfolio in Review
As of Q3 2024, Oarsman Capital held 907 positions worth $543M, up 19% from $457M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Oarsman Capital deployed $60.6M of net new capital in Q3 2024, opening 674 new positions and adding to 113 existing holdings. Its largest new stake was Vanguard Total Bond Market: 10,356 shares worth $778K.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $5.47M trimmed.
- Oarsman Capital's largest Q3 2024 buy was Vanguard Total Bond Market: 10,356 shares worth $778K.
- Oarsman Capital added most to Invesco S&P 500 Equal Weight ETF in Q3 2024, an estimated $12.8M increase.
- Oarsman Capital's biggest Q3 2024 reduction was Vanguard S&P 500 ETF, cutting an estimated $5.47M.
- Oarsman Capital's ten largest holdings make up 39% of its $543M portfolio in Q3 2024.
- Oarsman Capital opened 674 new positions and closed 0 in Q3 2024.
- Oarsman Capital's portfolio value rose 19% quarter-over-quarter to $543M.
Based on Oarsman Capital's 13F filing for Q3 2024, filed 8 Nov 2024.